- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
NANO
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT Nanotech Indonesia Global Tbk · Healthcare · Medical Devices
Latest close
29.00 IDR
0.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -17.7% below the Trend Line and sits at 13.2% of its 52-week range. The latest completed week returned 0.0%, after a 31.8% four-week move. The latest news-sentiment score is 49/100. Near-term considerations: volume confirmation is below normal.
Setup score
36
out of 100
Latest Close
29.00 IDR
7 Aug 2026
1W Return
0.0%
latest completed week
4W Return
31.8%
short-term follow-through
12W Return
-14.7%
quarterly tape
Trend Breadth
46.2%
24 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Next-week expectancy is negative at 30.37% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.0%
Latest completed week; four-week move 31.8%.
Indicator stack
25/72
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 30.37%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
49/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -17.7% below the Trend Line and sits at 13.2% of its 52-week range. The latest completed week returned 0.0%, after a 31.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0612-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 31.8% over four weeks, -14.7% over 12 weeks, and 11.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year24
Trend breadth46.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.58Latest activity-pressure read.
Pressure change142.9%Four-week change in activity pressure.
Leadership-19.54Latest relative-leadership reading.
RS change39.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment49/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 2 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-67.0%Distance below the 52-week high.
13-week volatility17.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher8 of 2611 weeks finished lower.
Best week+50.0%Week of 17 Jul.
Worst week-26.5%Week of 22 May.
Latest week+0.0%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains1
Flat weeks7
Modest losses1
Sharp losses10
Recent vol17.6%13-week weekly-return volatility.
Base vol16.2%52-week weekly-return volatility.
Up/down split19/22Count of positive and negative weeks in the 52-week window.
Average skew16.3% / -10.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank1 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Medical Devices
4-week rank1 / 3
Group average15.6%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD66.7%positive activity pressure
RS66.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis13/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 30.37%Next-week expectancy is negative with a 30.37% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment49/100Weighted news tone is neutral across 3 relevant articles.
Price to earnings forward of PT Nanotech Indonesia Global Tbk – IDX:NANO Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 29.00 IDR | 0.0% | 35.23 IDR | 27.86 IDR | 0.58 | -19.54 | 108.8M | Off |
| 31 Jul 2026 | 29.00 IDR | 0.0% | 36.00 IDR | 27.81 IDR | 0.14 | -16.99 | 324.1M | Off |
| 24 Jul 2026 | 29.00 IDR | -12.1% | 36.70 IDR | 27.76 IDR | -0.46 | -16.00 | 353.1M | Off |
| 17 Jul 2026 | 33.00 IDR | 50.0% | 37.03 IDR | 27.70 IDR | -0.93 | -3.50 | 217.3M | Off |
| 10 Jul 2026 | 22.00 IDR | 0.0% | 37.40 IDR | 27.62 IDR | -1.35 | -32.43 | 116.0M | Off |
| 3 Jul 2026 | 22.00 IDR | 0.0% | 38.30 IDR | 27.61 IDR | -1.38 | -31.79 | 30.9M | Off |
| 26 Jun 2026 | 22.00 IDR | -15.4% | 39.30 IDR | 27.60 IDR | -1.40 | -31.93 | 43.9M | Off |
| 19 Jun 2026 | 26.00 IDR | 4.0% | 40.30 IDR | 27.60 IDR | -1.49 | -23.15 | 10.1M | Off |
| 12 Jun 2026 | 25.00 IDR | 13.6% | 41.23 IDR | 27.56 IDR | -1.62 | -23.75 | 17.8M | Off |
| 5 Jun 2026 | 22.00 IDR | -15.4% | 42.27 IDR | 27.54 IDR | -1.51 | -27.85 | 20.3M | Off |
| 29 May 2026 | 26.00 IDR | 4.0% | 43.30 IDR | 27.54 IDR | -1.38 | -22.06 | 77.7M | Off |
| 22 May 2026 | 25.00 IDR | -26.5% | 44.30 IDR | 27.51 IDR | -1.29 | -25.28 | 184.9M | Off |
| 15 May 2026 | 34.00 IDR | 3.0% | 45.30 IDR | 27.49 IDR | -1.26 | -6.72 | 99.1M | Off |
| 8 May 2026 | 33.00 IDR | -13.2% | 45.80 IDR | 27.42 IDR | -1.28 | -12.27 | 268.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.